3-FEA: Difference between revisions

Line 6:

| ''[[3-FEA/Summary|Summary sheet: 3-FEA]]''

|}

'''3-Fluoroethamphetamine''' (also known as '''3-FEA''') is a novel synthetic ring-substituted fluorinated [[chemical class::amphetamine]] compound that produces a mixture [[psychoactive class::entactogen]]ic and [[psychoactive class::stimulant]] effects when [[Routes of administration|administered]] (typically [[oral]]ly due to its reported causticity){{citation needed}}. It is part of a series of [[designer drug]] fluorinated [[substituted amphetamine]] analogs that include such compounds as [[2-FA]], [[2-FMA]], [[3-FA]] and [[4-FA]].

'''3-Fluoroethamphetamine''' (also known as '''3-FEA''') is a novel synthetic ring-substituted fluorinated [[chemical class::amphetamine]] compound that produces a mixture [[psychoactive class::entactogen]]ic and [[psychoactive class::stimulant]] effects when [[Routes of administration|administered]] (typically [[oral]]ly due to its reported causticity){{citation needed}}. It is part of a series of [[designer drug|designer]] fluorinated [[substituted amphetamine]] analogs that include such compounds as [[2-FA]], [[2-FMA]], [[3-FA]] and [[4-FA]].

Like its parent compound [[3-FA]], the pharmacological, toxicological, and subjective effects of 3-FEA in humans have yet to be mapped out in detail. Early reports have so far characterized 3-FEA as a moderately potent [[serotonin]]-dominant triple [[monoamine releaser]] (or triple [[reuptake inhibitor]]) that produces a unique balance of [[entactogen]]ic and [[stimulant]] effects that skews more to the hedonic-euphoric side (like one of its popular predecessor [[4-FA]]), than towards the functional and productive (e.g. as [[2-FA]] or [[2-FMA]] are considered to be).

@@ Line 6: / Line 6: @@
 | ''[[3-FEA/Summary|Summary sheet: 3-FEA]]''
 |}
-'''3-Fluoroethamphetamine''' (also known as '''3-FEA''') is a novel synthetic ring-substituted fluorinated [[chemical class::amphetamine]] compound that produces a mixture [[psychoactive class::entactogen]]ic and [[psychoactive class::stimulant]] effects when [[Routes of administration|administered]] (typically [[oral]]ly due to its reported causticity){{citation needed}}. It is part of a series of [[designer drug]] fluorinated [[substituted amphetamine]] analogs that include such compounds as [[2-FA]], [[2-FMA]], [[3-FA]] and [[4-FA]].
+'''3-Fluoroethamphetamine''' (also known as '''3-FEA''') is a novel synthetic ring-substituted fluorinated [[chemical class::amphetamine]] compound that produces a mixture [[psychoactive class::entactogen]]ic and [[psychoactive class::stimulant]] effects when [[Routes of administration|administered]] (typically [[oral]]ly due to its reported causticity){{citation needed}}. It is part of a series of [[designer drug|designer]] fluorinated [[substituted amphetamine]] analogs that include such compounds as [[2-FA]], [[2-FMA]], [[3-FA]] and [[4-FA]].
 Like its parent compound [[3-FA]], the pharmacological, toxicological, and subjective effects of 3-FEA in humans have yet to be mapped out in detail. Early reports have so far characterized 3-FEA as a moderately potent [[serotonin]]-dominant triple [[monoamine releaser]] (or triple [[reuptake inhibitor]]) that produces a unique balance of [[entactogen]]ic and [[stimulant]] effects that skews more to the hedonic-euphoric side (like one of its popular predecessor [[4-FA]]), than towards the functional and productive (e.g. as [[2-FA]] or [[2-FMA]] are considered to be).